115 related articles for article (PubMed ID: 3497869)
21. Modulation of natural killer cell-mediated cytotoxicity by tamoxifen and estradiol.
Baral E; Nagy E; Berczi I
Cancer; 1995 Jan; 75(2):591-9. PubMed ID: 7812928
[TBL] [Abstract][Full Text] [Related]
22. Lymphokine-activated killer cells: lysis of fresh syngeneic natural killer-resistant murine tumor cells by lymphocytes cultured in interleukin 2.
Rosenstein M; Yron I; Kaufmann Y; Rosenberg SA
Cancer Res; 1984 May; 44(5):1946-53. PubMed ID: 6608989
[TBL] [Abstract][Full Text] [Related]
23. YAC-1 variant clones selected for resistance to natural killer cytotoxic factors are also resistant to natural killer cell-mediated cytotoxicity.
Wright SC; Bonavida B
Proc Natl Acad Sci U S A; 1983 Mar; 80(6):1688-92. PubMed ID: 6572932
[TBL] [Abstract][Full Text] [Related]
24. Lack of reconstitution of nude mice alloreactivity by purified interleukin 2 and induction of non-H-2-specific effector cells by crude supernatants.
Harel-Bellan A; Quillet A; Marchiol C; Gerard JP; Fradelizi D
Cell Immunol; 1987 Apr; 105(2):251-61. PubMed ID: 3494525
[TBL] [Abstract][Full Text] [Related]
25. Studies on the mechanism of natural killer cytotoxicity. III. Activation of NK cells by interferon augments the lytic activity of released natural killer cytotoxic factors (NKCF).
Wright SC; Bonavida B
J Immunol; 1983 Jun; 130(6):2960-4. PubMed ID: 6189908
[TBL] [Abstract][Full Text] [Related]
26. Natural killer (NK) cell activity in mice with acute graft-versus-host reactions: characterization of a Thy-1+ NK-like cell with a broadened spectrum of lytic activity in the spleen and lymph nodes.
MacDonald GC; Gartner JG
Scand J Immunol; 1991 May; 33(5):553-65. PubMed ID: 1709518
[TBL] [Abstract][Full Text] [Related]
27. Heterogeneity of lymphokine-activated killer cells induced by IL-2. Separate lymphoid subpopulations lyse tumor, allogeneic blasts, and modified syngeneic blasts.
LeFor AT; Eisenthal A; Rosenberg SA
J Immunol; 1988 Jun; 140(11):4062-9. PubMed ID: 3259603
[TBL] [Abstract][Full Text] [Related]
28. Systemic administration of recombinant interleukin-6 in mice induces proliferation of lymphoid cells in vivo.
Puri RK; Leland P
Lymphokine Cytokine Res; 1992 Jun; 11(3):133-9. PubMed ID: 1391232
[TBL] [Abstract][Full Text] [Related]
29. Killer-cell lines derived from mouse thymus, resembling large granular lymphocytes and expressing natural killer-like cytotoxicity.
Born W; Ben-Nun A; Bamberger U; Nakayama M; Speth V; Sun D; Thornton M
Immunobiology; 1983 Jul; 165(1):63-77. PubMed ID: 6885103
[TBL] [Abstract][Full Text] [Related]
30. Effect of methyl linoleate hydroperoxides on murine natural killer cell-mediated cytotoxicity.
Oarada M; Kurita N; Terao K; Miyaji M
J Nutr Sci Vitaminol (Tokyo); 1995 Dec; 41(6):707-11. PubMed ID: 8926542
[TBL] [Abstract][Full Text] [Related]
31. Natural killer activity in cloned cytotoxic T lymphocytes: regulation by interleukin 2, interferon, and specific antigen.
Brooks CG; Holscher M; Urdal D
J Immunol; 1985 Aug; 135(2):1145-52. PubMed ID: 2409140
[TBL] [Abstract][Full Text] [Related]
32. Characterization and partial purification of a specific interleukin 2 inhibitor.
Honda M; Chan C; Shevach EM
J Immunol; 1985 Sep; 135(3):1834-9. PubMed ID: 3926886
[TBL] [Abstract][Full Text] [Related]
33. Hybrid resistance to EL-4 lymphoma cells. I. Characterization of natural killer cells that lyse EL-4 cells and their distinction from marrow-dependent natural killer cells.
Kumar V; Luevano E; Bennett M
J Exp Med; 1979 Sep; 150(3):531-47. PubMed ID: 383877
[TBL] [Abstract][Full Text] [Related]
34. H-2 antigen expression and sensitivity of BL6 melanoma cells to natural killer cell cytotoxicity.
Gorelik E; Gunji Y; Herberman RB
J Immunol; 1988 Mar; 140(6):2096-102. PubMed ID: 3126240
[TBL] [Abstract][Full Text] [Related]
35. Natural killer cell activity in murine muscular dystrophy. III. NK-sensitive myoblast cells and lack of NK activity in beige/dystrophic hybrid mice.
Semple JW; Szewczuk MR
Cell Immunol; 1986 Jun; 100(1):20-33. PubMed ID: 3742600
[TBL] [Abstract][Full Text] [Related]
36. Lectin-induced cytotoxic activity in spleen cells from young and old mice. Age-related changes in types of effector cells, lymphokine production and response.
Saxena RK; Saxena QB; Adler WH
Immunology; 1988 Jul; 64(3):457-61. PubMed ID: 3137156
[TBL] [Abstract][Full Text] [Related]
37. Enhanced generation of OK-432-induced killer cells by interleukin 2.
Ujiie T
Jpn J Exp Med; 1987 Jun; 57(3):183-8. PubMed ID: 3500332
[TBL] [Abstract][Full Text] [Related]
38. Cytokine production and killer activity of NK/T-NK cells derived with IL-2, IL-15, or the combination of IL-12 and IL-18.
Lauwerys BR; Garot N; Renauld JC; Houssiau FA
J Immunol; 2000 Aug; 165(4):1847-53. PubMed ID: 10925263
[TBL] [Abstract][Full Text] [Related]
39. Monoclonal antibody against human interleukin 2 (IL 2). I. Purification of IL 2 for the production of monoclonal antibodies.
Stadler BM; Berenstein EH; Siraganian RP; Oppenheim JJ
J Immunol; 1982 Apr; 128(4):1620-4. PubMed ID: 6977565
[TBL] [Abstract][Full Text] [Related]
40. Lysis of NK target cells by soluble cytotoxic factor(s) and inhibition by a xenoantiserum directed against cytotoxic cells.
Wright SC; Hiserodt JC; Bonavida B
Transplant Proc; 1981 Mar; 13(1 Pt 2):770-3. PubMed ID: 7268895
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
